CALLIE TALLEY: Open Payments
NPI 1871207654 · PARAGOULD, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$644 in 33 payments from 11 companies in 2025. Trend: 2023 $55 · 2024 $569 · 2025 $644
Food & beverage: $644
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $142 |
| Lilly USA, LLC | 1 | $97 |
| Lundbeck LLC | 4 | $74 |
| Janssen Pharmaceuticals, Inc | 3 | $62 |
| Alkermes, Inc. | 3 | $51 |
| Neurocrine BioSciences, Inc. | 3 | $50 |
| Axsome Therapeutics, Inc. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Tris Pharma Inc | 2 | $37 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: MOUNJARO, REXULTI, UBRELVY, VRAYLAR, ARISTADA, INGREZZA, Auvelity, SPRAVATO.
Industry payments across AR — which companies pay providers there.
